ArticleJAMA network open2026
Performance of a Sepsis Prediction Model Across Different Sepsis Definitions.
Article in JAMA network open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Patient Versus Prediction-Level Evaluation of a Dynamic Clinical Prediction Model of Sepsis.Research square · 2026Article
- Patient Versus Prediction-Level Evaluation of a Dynamic Clinical Prediction Model of Sepsis.medRxiv : the preprint server for health sciences · 2026Article
- Construction and validation of a sepsis prediction model using inflammatory and hemodynamic markers in the emergency department.Frontiers in medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Importance: Early detection of sepsis improves clinical outcomes, but the Early Detection of Sepsis Model, version 1 (Epic Systems Corp) has shown poor performance. Comparing sepsis models is complicated by varying outcome definitions and limited generalizability outside the development site. Objective: To evaluate the Early Detection of Sepsis Model, version 2 using multiple standard sepsis definitions. Design, Setting, and Participants: This diagnostic study included all adult (aged ≥18 years) encounters from emergency departments, inpatient units, intensive care units, and perioperative areas across 9 acute care hospitals between March 17 and August 31, 2024. The locally trained gradient-boosted tree ensemble sepsis model, incorporating patient demographics, vital signs, laboratory results, medication administration, and other clinical features, generated predictions every 15 minutes. Model performance was evaluated against 3 electronically computable sepsis definitions: the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3); Centers for Medicare & Medicaid Services Severe Sepsis and Septic Shock: Management Bundle (SEP-1); and the Centers for Disease Control and Prevention Adult Sepsis Event (ASE). Exposure: Silent deployment of the sepsis model. Main Outcomes and Measures: Model performance metrics included discrimination, as measured using the area under the receiver operating characteristic curve (AUROC), and precision, as measured by the area under the precision-recall curve (AUPRC). Test characteristics and potential lead-time warning were evaluated over a range of model score thresholds. Results: Among 198 494 patient encounters (median [IQR] age, 55 [36-71] years; 54.8% female) the incidence of sepsis varied by outcome definition. A total of 5832 encounters (2.9%) met the Sepsis-3 definition, 2366 (1.2%) met the SEP-1 definition, and 3881 (2.0%) met the ASE definition. The AUROC and AUPRC were, respectively, 0.89 (95% CI, 0.89-0.90) and 0.24 (95% CI, 0.23-0.25) for Sepsis-3, 0.94 (95% CI, 0.94-0.94) and 0.16 (95% CI, 0.15-0.17) for SEP-1, and 0.85 (95% CI, 0.85-0.86) and 0.11 (95% CI, 0.11-0.12) for ASE. In the overall study population, the Youden top left threshold for the Sepsis-3 outcome definition was 9, which yielded a positive predictive (PPV) of 11.4% (95% CI, 11.1%-11.7%) and median lead time of 3.4 hours (IQR, 0.9-22.3 hours). The SEP-1 had a PPV of 6.8 (95% CI, 6.6-7.1 9.9) and median (IQR) lead time of 4.5 (4.3-23.1) hours, and the ASE had a PPV of 5.9 (95% CI, 5.7-6.0) and median (IQR) lead time of 1.4 (0.5-14.8) hours. Conclusions and Relevance: This cohort study found that the locally trained sepsis model showed moderate predictive performance, with discrimination, precision, and lead time varying considerably by the sepsis definition applied. Although the model provided some advance warning before sepsis onset, a high false-positive rate may limit its clinical utility without careful threshold selection and tailored implementation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.